Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Mean Normalized Growth Rate Inhibition Value Increased Fraction Dead
Hs 578T BMS-265246
0.316227766
0.2434 0.13722
Hs 578T BMS-265246
1.0
0.2105 0.13733
Hs 578T BMS-265246
1.0
0.1482 0.09539
Hs 578T BMS-265246
1.0
0.2918 0.07475
Hs 578T BMS-265246
3.16227766
0.0846 0.12159
Hs 578T BMS-265246
3.16227766
0.0571 0.13503
Hs 578T BMS-265246
3.16227766
0.0500 0.20913
Hs 578T BMS-265246
10.0
-0.0047 0.25386
Hs 578T BMS-265246
10.0
0.89326
Hs 578T BMS-265246
10.0
-0.0601 0.28896
Hs 578T Ulixertinib
0.001
0.9987 0.00368
Hs 578T Ulixertinib
0.001
1.0086 0.03848
Hs 578T Ulixertinib
0.001
0.9411 0.00431
Hs 578T Ulixertinib
0.003162278
0.9127 0.01667
Hs 578T Ulixertinib
0.003162278
0.9744 0.02367
Hs 578T Ulixertinib
0.003162278
0.8950 0.05362
Hs 578T Ulixertinib
0.01
0.8715 0.01652
Hs 578T Ulixertinib
0.01
0.9015 0.05635
Hs 578T Ulixertinib
0.01
0.8638 0.01926
Hs 578T Ulixertinib
0.031622777
0.6911 0.13153
Hs 578T Ulixertinib
0.031622777
0.8413 0.07445
Hs 578T Ulixertinib
0.031622777
0.7545 0.08620
Hs 578T Ulixertinib
0.1
0.7351 0.08334
Hs 578T Ulixertinib
0.1
0.7405 0.07292
Hs 578T Ulixertinib
0.1
0.7224 0.08812